Barrett's esophagus: proton pump inhibitors and chemoprevention II

The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48‐h pH monitoring, pH‐impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dua...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of the New York Academy of Sciences 2011-09, Vol.1232 (1), p.114-139
Hauptverfasser:	Richter, Joel E., Penagini, Roberto, Pohl, Daniel, Dvorak, Katerina, Goldman, Aaron, Savarino, Edoardo, Zentilin, Patrizia, Savarino, Vincenzo, Watson, Joshua T., Wong, Roy K.H., Pace, Fabio, Casini, Valentina, Peura, David A., Herzig, Shoshana Joy, Kamiya, Takeshi, Pelosini, Iva, Scarpignato, Carmelo, Armstrong, David, DeVault, Kenneth R., Bechi, Paolo, Taddei, Antonio, Freschi, Giancarlo, Ringressi, Maria Novella, Degli'Innocenti, Duccio Rossi, Castiglione, Francesca, Masini, Emmanuella, Hunt, Richard H.
Format:	Artikel
Sprache:	eng
Schlagworte:	48-h acid reflux monitoring ACG guidelines acid suppression API-023 AspECT trial baclofen Barrett Esophagus - drug therapy Barrett's esophagus bile acids Bilitec probe Chemoprevention Clostridium difficile CMA omeprazole COX-2 inhibitors dexlansoprazole Drugs erosive esophigitis Esophagus functional dyspepsia functional heartburn fundic glands polyp GABAB GERD Humans ilaprazole Inhibitors Monitoring Monitoring, Physiologic NERD nocturnal acid breakthrough Nonsteroidal anti-inflammatory drugs Obesity pH testing pharmacokinetic changes PPI therapy Proton Pump Inhibitors - therapeutic use Pumps rabeprazole Segments Side effects STU-Na Symptom Association Probability tenatoprazole TLESR Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48‐h pH monitoring, pH‐impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual‐release delivery PPIs, immediate‐release PPIs, long‐term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti‐inflammatory drugs (NSAIDs), and new PPIs.
ISSN:	0077-8923 1749-6632
DOI:	10.1111/j.1749-6632.2011.06048.x